PATENT CLAIM ANALYSIS

Application Number: 16188988
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "217050"]

Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 18):
The method of  claim 13 , wherein the compound and the at least one additional therapeutic agent are co-administered.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.63265
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15863216', '15216119', '15914016', '12259483', '11503502']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000835490652712
- 35 USC 102 Novelty (BERT): 0.5316162236366241
- Combined Prediction Score: 0.7732368165224065
- Mean Citation Score: 318.27413799999994
- Max Citation Score: 351.35507
- Similarity Product: 318.70214979366415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test